Hong Y. Choi

951 total citations
25 papers, 763 citations indexed

About

Hong Y. Choi is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Hong Y. Choi has authored 25 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 10 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Hong Y. Choi's work include Lipoproteins and Cardiovascular Health (10 papers), Cholesterol and Lipid Metabolism (10 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Hong Y. Choi is often cited by papers focused on Lipoproteins and Cardiovascular Health (10 papers), Cholesterol and Lipid Metabolism (10 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Hong Y. Choi collaborates with scholars based in Canada, United States and France. Hong Y. Choi's co-authors include Joachim Herz, Jacques Genest, Marco Dieckmann, Andreas Niemeier, Teddy Chan, Gordon A. Francis, Adel Schwertani, Isabelle L. Ruel, Jean E. Vance and Barbara Karten and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Hong Y. Choi

25 papers receiving 750 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong Y. Choi Canada 13 353 342 134 125 118 25 763
Ferdous M. Barlaskar United States 8 297 0.8× 258 0.8× 260 1.9× 122 1.0× 172 1.5× 10 697
Tiffany Tseng United States 6 302 0.9× 319 0.9× 85 0.6× 132 1.1× 137 1.2× 8 659
Barbara Salani Italy 16 183 0.5× 547 1.6× 211 1.6× 116 0.9× 109 0.9× 27 873
Nicole Liadis Canada 11 226 0.6× 393 1.1× 80 0.6× 187 1.5× 88 0.7× 15 761
Gong-Qing Shen United States 14 212 0.6× 461 1.3× 138 1.0× 84 0.7× 142 1.2× 25 1.1k
Chantal Samson France 12 150 0.4× 303 0.9× 65 0.5× 56 0.4× 125 1.1× 13 592
Jan‐Marcus Daniel Germany 15 106 0.3× 609 1.8× 191 1.4× 99 0.8× 71 0.6× 31 992
Avital Swisa Israel 16 586 1.7× 755 2.2× 138 1.0× 111 0.9× 255 2.2× 19 1.3k
Jingzhen Yuan United States 17 305 0.9× 603 1.8× 47 0.4× 205 1.6× 46 0.4× 24 962

Countries citing papers authored by Hong Y. Choi

Since Specialization
Citations

This map shows the geographic impact of Hong Y. Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Y. Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Y. Choi more than expected).

Fields of papers citing papers by Hong Y. Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Y. Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Y. Choi. The network helps show where Hong Y. Choi may publish in the future.

Co-authorship network of co-authors of Hong Y. Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Y. Choi. A scholar is included among the top collaborators of Hong Y. Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Y. Choi. Hong Y. Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choi, Hong Y., et al.. (2023). Biomedical Advances in ABCA1 Transporter: From Bench to Bedside. Biomedicines. 11(2). 561–561. 7 indexed citations
2.
Iatan, Iulia, Hong Y. Choi, & Jacques Genest. (2022). High-Density Lipoprotein and Cardiovascular Disease—Where do We Stand?. Endocrinology and Metabolism Clinics of North America. 51(3). 557–572. 5 indexed citations
3.
Choi, Hong Y., et al.. (2022). Repurposing the anti-cancer drug docetaxel for the prevention and treatment of atherosclerosis. Atherosclerosis. 355. 69–69. 1 indexed citations
4.
Choi, Hong Y., et al.. (2021). New Strategies to Promote Macrophage Cholesterol Efflux. Frontiers in Cardiovascular Medicine. 8. 795868–795868. 11 indexed citations
5.
Choi, Hong Y., Isabelle L. Ruel, & Jacques Genest. (2021). Identification of Docetaxel as a Potential Drug to Promote HDL Biogenesis. Frontiers in Pharmacology. 12. 679456–679456. 6 indexed citations
6.
Schwertani, Adel, Hong Y. Choi, & Jacques Genest. (2018). HDLs and the pathogenesis of atherosclerosis. Current Opinion in Cardiology. 33(3). 311–316. 19 indexed citations
7.
Choi, Hong Y., Isabelle L. Ruel, Adel Schwertani, & Jacques Genest. (2018). Desmocollin 1 is Abundantly Expressed in Atherosclerosis and Impairs High-density Lipoprotein Biogenesis. Atherosclerosis Supplements. 32. 28–28. 1 indexed citations
8.
Choi, Hong Y., Isabelle L. Ruel, Abba Malina, et al.. (2017). Desmocollin 1 is abundantly expressed in atherosclerosis and impairs high-density lipoprotein biogenesis. European Heart Journal. 39(14). 1194–1202. 18 indexed citations
9.
Genest, Jacques & Hong Y. Choi. (2017). Novel Approaches for HDL-Directed Therapies. Current Atherosclerosis Reports. 19(12). 55–55. 11 indexed citations
10.
Genest, Jacques, Adel Schwertani, & Hong Y. Choi. (2017). Membrane microdomains and the regulation of HDL biogenesis. Current Opinion in Lipidology. 29(1). 36–41. 12 indexed citations
11.
Choi, Hong Y., Anouar Hafiane, Adel Schwertani, & Jacques Genest. (2016). High-Density Lipoproteins: Biology, Epidemiology, and Clinical Management. Canadian Journal of Cardiology. 33(3). 325–333. 40 indexed citations
12.
Choi, Hong Y., et al.. (2013). Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in Acute Coronary Syndrome: Relationship With Low-Density Lipoprotein Cholesterol. Canadian Journal of Cardiology. 29(12). 1679–1686. 13 indexed citations
13.
Awan, Zuhier, Hong Y. Choi, Nathan O. Stitziel, et al.. (2013). APOE p.Leu167del mutation in familial hypercholesterolemia. Atherosclerosis. 231(2). 218–222. 81 indexed citations
14.
Choi, Hong Y., et al.. (2013). Abstract 441: Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) is Elevated in Acute Coronary Syndromes and Resides Predominantly in LDL. Arteriosclerosis Thrombosis and Vascular Biology. 33(suppl_1). 1 indexed citations
15.
Zhou, Li, Hong Y. Choi, Wei-Ping Li, Fang Xu, & Joachim Herz. (2009). LRP1 Controls cPLA2 Phosphorylation, ABCA1 Expression and Cellular Cholesterol Export. PLoS ONE. 4(8). e6853–e6853. 37 indexed citations
16.
Choi, Hong Y., Marco Dieckmann, Joachim Herz, & Andreas Niemeier. (2009). Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo. PLoS ONE. 4(11). e7930–e7930. 172 indexed citations
17.
Ohazama, Atsushi, James Blackburn, Thantrira Porntaveetus, et al.. (2009). A role for suppressed incisor cuspal morphogenesis in the evolution of mammalian heterodont dentition. Proceedings of the National Academy of Sciences. 107(1). 92–97. 34 indexed citations
18.
Choi, Hong Y., Emma Waddington, Teddy Chan, et al.. (2006). Correction of Apolipoprotein A-I-mediated Lipid Efflux and High Density Lipoprotein Particle Formation in Human Niemann-Pick Type C Disease Fibroblasts. Journal of Biological Chemistry. 281(48). 37081–37090. 36 indexed citations
19.
Choi, Hong Y., Barbara Karten, Teddy Chan, et al.. (2003). Impaired ABCA1-dependent Lipid Efflux and Hypoalphalipoproteinemia in Human Niemann-Pick type C Disease. Journal of Biological Chemistry. 278(35). 32569–32577. 123 indexed citations
20.
Choi, Hong Y., et al.. (2000). The effects of ascorbic acid on dopamine-induced death of PC12 cells are dependent on exposure kinetics. Neuroscience Letters. 296(2-3). 81–84. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ferdous M. Barlaskar Breakdown of academic impact, for papers by Tiffany Tseng Breakdown of academic impact, for papers by Barbara Salani Breakdown of academic impact, for papers by Nicole Liadis Breakdown of academic impact, for papers by Gong-Qing Shen Breakdown of academic impact, for papers by Chantal Samson Breakdown of academic impact, for papers by Jan‐Marcus Daniel Breakdown of academic impact, for papers by Avital Swisa Breakdown of academic impact, for papers by Jingzhen Yuan
Rankless by CCL
2026